Home › Funds › Citadel Advisors › TXMD
Citadel Advisors position in TXMD
THERAPEUTICSMD INC · Health Care
Latest position (Q2 2026)86.09K sh
Reported value held$190.27K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 433.51K | $321.00K | New |
| Q4 2021 | 549.19K | $196.00K | Add |
| Q1 2022 | 245.46K | $93.00K | Reduce |
| Q2 2022 | 14.20K | $141.00K | Reduce |
| Q3 2022 | 62.56K | $415.00K | Add |
| Q4 2022 | 64.76K | $362.01K | Add |
| Q1 2023 | 38.70K | $145.11K | Reduce |
| Q2 2023 | 33.72K | $138.91K | Reduce |
| Q3 2023 | 25.50K | $77.00K | Reduce |
| Q4 2023 | 14.70K | $33.07K | Reduce |
| Q1 2024 | 12.26K | $28.08K | Reduce |
| Q2 2024 | 10.88K | $17.51K | Reduce |
| Q3 2024 | 11.60K | $19.26K | Add |
| Q4 2024 | 152.80K | $131.43K | Add |
| Q1 2025 | 17.40K | $16.09K | Reduce |
| Q1 2025 | 17.40K | $16.09K | Reduce |
| Q2 2025 | 15.20K | $17.63K | Reduce |
| Q2 2025 | 15.20K | $17.63K | Reduce |
| Q3 2025 | 34.27K | $36.33K | Add |
| Q4 2025 | 48.84K | $79.61K | Add |
| Q1 2026 | 95.11K | $192.13K | Add |
| Q2 2026 | 86.09K | $190.27K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TXMD
- Vanguard Group 397.06K sh · $647.20K · Q4 2025
- Renaissance Technologies 146.60K sh · $323.98K · Q2 2026
- Morgan Stanley 129.22K sh · $285.57K · Q2 2026
- BlackRock Inc 115.14K sh · $254.47K · Q2 2026
- Geode Capital Management 105.85K sh · $233.99K · Q2 2026
- Northern Trust Corp 18.56K sh · $41.01K · Q2 2026
- UBS Group AG 4.66K sh · $10.30K · Q2 2026
- JPMorgan Chase & Co 293 sh · $657 · Q2 2026
- Wells Fargo & Co 115 sh · $254 · Q2 2026
- Citigroup Inc 64 sh · $141 · Q2 2026